Cargando…
Effect of elevated fasting blood glucose level on the 1‐year mortality and sequelae in hospitalized COVID‐19 patients: A bidirectional cohort study
To observe the predictive effect of fasting blood glucose (FBG) level on the prognosis, clinical sequelae, and pulmonary absorption in hospitalized coronavirus disease 2019 (COVID‐19) patients with and without a history of diabetes, respectively, and to evaluate the correlation between the dynamic c...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9088618/ https://www.ncbi.nlm.nih.gov/pubmed/35357022 http://dx.doi.org/10.1002/jmv.27737 |
_version_ | 1784704358549553152 |
---|---|
author | Chai, Chen Chen, Kui Li, Shoupeng Cheng, Gang Wang, Wendan Wang, Hongxiang Wei, Dunshuang Peng, Cao Sun, Qi Tang, Zehai |
author_facet | Chai, Chen Chen, Kui Li, Shoupeng Cheng, Gang Wang, Wendan Wang, Hongxiang Wei, Dunshuang Peng, Cao Sun, Qi Tang, Zehai |
author_sort | Chai, Chen |
collection | PubMed |
description | To observe the predictive effect of fasting blood glucose (FBG) level on the prognosis, clinical sequelae, and pulmonary absorption in hospitalized coronavirus disease 2019 (COVID‐19) patients with and without a history of diabetes, respectively, and to evaluate the correlation between the dynamic changes of FBG and poor prognosis. In this bidirectional cohort study, we enrolled 2545 hospitalized COVID‐19 patients (439 diabetics and 2106 without a diabetic history) and followed up for 1 year. The patients were divided according to the level of admission FBG. The dynamic changes of FBG were compared between the survival and the death cases. The prediction effect of FBG on 1‐year mortality and sequelae was analyzed. The 1‐year all cause mortality rate and in‐hospital mortality rate of COVID‐19 patients were J‐curve correlated with FBG (p < 0.001 for both in the nondiabetic history group, p = 0.004 and p = 0.01 in the diabetic history group). FBG ≥ 7.0 mmol/L had a higher risk of developing sequelae (p = 0.025) and have slower recovery of abnormal lung scans (p < 0.001) in patients who denied a history of diabetes. Multivariable Cox regression analysis showed that FBG ≥ 7.0 mmol/L was an independent risk factor for the mortality of COVID‐19 regardless of the presence or deny a history of diabetes (hazard atio [HR] = 10.63, 95% confidence interval [CI]: 7.15−15.83, p < 0.001; HR = 3.9, 95% CI: 1.56−9.77, p = 0.004, respectively). Our study shows that FBG ≥ 7.0 mmol/L can be a predictive factor of 1‐year all‐cause mortality in COVID‐19 patients, independent of diabetes history. FBG ≥ 7.0 mmol/L has an advantage in predicting the severity, clinical sequelae, and pulmonary absorption in COVID‐19 patients without a history of diabetes. Early detection, timely treatment, and strict control of blood glucose when finding hyperglycemia in COVID‐19 patients (with or without diabetes) are critical for their prognosis. |
format | Online Article Text |
id | pubmed-9088618 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-90886182022-05-10 Effect of elevated fasting blood glucose level on the 1‐year mortality and sequelae in hospitalized COVID‐19 patients: A bidirectional cohort study Chai, Chen Chen, Kui Li, Shoupeng Cheng, Gang Wang, Wendan Wang, Hongxiang Wei, Dunshuang Peng, Cao Sun, Qi Tang, Zehai J Med Virol Research Articles To observe the predictive effect of fasting blood glucose (FBG) level on the prognosis, clinical sequelae, and pulmonary absorption in hospitalized coronavirus disease 2019 (COVID‐19) patients with and without a history of diabetes, respectively, and to evaluate the correlation between the dynamic changes of FBG and poor prognosis. In this bidirectional cohort study, we enrolled 2545 hospitalized COVID‐19 patients (439 diabetics and 2106 without a diabetic history) and followed up for 1 year. The patients were divided according to the level of admission FBG. The dynamic changes of FBG were compared between the survival and the death cases. The prediction effect of FBG on 1‐year mortality and sequelae was analyzed. The 1‐year all cause mortality rate and in‐hospital mortality rate of COVID‐19 patients were J‐curve correlated with FBG (p < 0.001 for both in the nondiabetic history group, p = 0.004 and p = 0.01 in the diabetic history group). FBG ≥ 7.0 mmol/L had a higher risk of developing sequelae (p = 0.025) and have slower recovery of abnormal lung scans (p < 0.001) in patients who denied a history of diabetes. Multivariable Cox regression analysis showed that FBG ≥ 7.0 mmol/L was an independent risk factor for the mortality of COVID‐19 regardless of the presence or deny a history of diabetes (hazard atio [HR] = 10.63, 95% confidence interval [CI]: 7.15−15.83, p < 0.001; HR = 3.9, 95% CI: 1.56−9.77, p = 0.004, respectively). Our study shows that FBG ≥ 7.0 mmol/L can be a predictive factor of 1‐year all‐cause mortality in COVID‐19 patients, independent of diabetes history. FBG ≥ 7.0 mmol/L has an advantage in predicting the severity, clinical sequelae, and pulmonary absorption in COVID‐19 patients without a history of diabetes. Early detection, timely treatment, and strict control of blood glucose when finding hyperglycemia in COVID‐19 patients (with or without diabetes) are critical for their prognosis. John Wiley and Sons Inc. 2022-04-19 2022-07 /pmc/articles/PMC9088618/ /pubmed/35357022 http://dx.doi.org/10.1002/jmv.27737 Text en © 2022 The Authors. Journal of Medical Virology published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Articles Chai, Chen Chen, Kui Li, Shoupeng Cheng, Gang Wang, Wendan Wang, Hongxiang Wei, Dunshuang Peng, Cao Sun, Qi Tang, Zehai Effect of elevated fasting blood glucose level on the 1‐year mortality and sequelae in hospitalized COVID‐19 patients: A bidirectional cohort study |
title | Effect of elevated fasting blood glucose level on the 1‐year mortality and sequelae in hospitalized COVID‐19 patients: A bidirectional cohort study |
title_full | Effect of elevated fasting blood glucose level on the 1‐year mortality and sequelae in hospitalized COVID‐19 patients: A bidirectional cohort study |
title_fullStr | Effect of elevated fasting blood glucose level on the 1‐year mortality and sequelae in hospitalized COVID‐19 patients: A bidirectional cohort study |
title_full_unstemmed | Effect of elevated fasting blood glucose level on the 1‐year mortality and sequelae in hospitalized COVID‐19 patients: A bidirectional cohort study |
title_short | Effect of elevated fasting blood glucose level on the 1‐year mortality and sequelae in hospitalized COVID‐19 patients: A bidirectional cohort study |
title_sort | effect of elevated fasting blood glucose level on the 1‐year mortality and sequelae in hospitalized covid‐19 patients: a bidirectional cohort study |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9088618/ https://www.ncbi.nlm.nih.gov/pubmed/35357022 http://dx.doi.org/10.1002/jmv.27737 |
work_keys_str_mv | AT chaichen effectofelevatedfastingbloodglucoselevelonthe1yearmortalityandsequelaeinhospitalizedcovid19patientsabidirectionalcohortstudy AT chenkui effectofelevatedfastingbloodglucoselevelonthe1yearmortalityandsequelaeinhospitalizedcovid19patientsabidirectionalcohortstudy AT lishoupeng effectofelevatedfastingbloodglucoselevelonthe1yearmortalityandsequelaeinhospitalizedcovid19patientsabidirectionalcohortstudy AT chenggang effectofelevatedfastingbloodglucoselevelonthe1yearmortalityandsequelaeinhospitalizedcovid19patientsabidirectionalcohortstudy AT wangwendan effectofelevatedfastingbloodglucoselevelonthe1yearmortalityandsequelaeinhospitalizedcovid19patientsabidirectionalcohortstudy AT wanghongxiang effectofelevatedfastingbloodglucoselevelonthe1yearmortalityandsequelaeinhospitalizedcovid19patientsabidirectionalcohortstudy AT weidunshuang effectofelevatedfastingbloodglucoselevelonthe1yearmortalityandsequelaeinhospitalizedcovid19patientsabidirectionalcohortstudy AT pengcao effectofelevatedfastingbloodglucoselevelonthe1yearmortalityandsequelaeinhospitalizedcovid19patientsabidirectionalcohortstudy AT sunqi effectofelevatedfastingbloodglucoselevelonthe1yearmortalityandsequelaeinhospitalizedcovid19patientsabidirectionalcohortstudy AT tangzehai effectofelevatedfastingbloodglucoselevelonthe1yearmortalityandsequelaeinhospitalizedcovid19patientsabidirectionalcohortstudy |